What we want to be able to do is invest in new antibiotics in ways that actually encourage appropriate use and sales of those antibiotics, and that really is the challenge here.
We moeten in nieuwe antibiotica investeren op manieren die verantwoord gebruik en verkoop van die antibiotica stimuleren, en dat is hier de echte uitdaging.